期刊文献+

Effects of TNFAIP3 and PDE4B on apoptosis and invasion of tumor cells in diffuse large B cell lymphoma

下载PDF
导出
摘要 Objective: To study the effects of TNFAIP3 and PDE4B on apoptosis and invasion of tumor cells in diffuse large B cell lymphoma. Methods: A total of 68 patients who were diagnosed with diffuse large B cell lymphoma in Guangzhou 421 Hospital of PLA between August 2014 and July 2017 were selected as the DLBCL group of the study, and 34 patients who accepted lymph node biopsy due to lymphadenectasis and were diagnosed with reactive lymphoid hyperplasias in Guangzhou 421 Hospital of PLA during the same period were selected as the control group. The expression levels of TNFAIP3, PDE4B, apoptosis genes and invasion genes in lymph node tissue were determined. Results: TNFAIP3, PTEN, PTPL1 and Bax protein expression in lesion tissue of DLBCL group were significantly lower than those of control group whereas PDE4B, c-myc, AURKA, AURKB, PLK1, Ets-1, β-catenin, MMP7, MMP9 and CD44 protein expression were significantly higher than those of control group;PTEN, PTPL1 and Bax protein expression in DLBCL lesions were positively correlated with TNFAIP3 protein expression and negatively correlated with PDE4B protein expression;c-myc, AURKA, AURKB, PLK1, Ets-1, β-catenin, MMP7, MMP9 and CD44 protein expression were negatively correlated with TNFAIP3 protein expression and positively correlated with PDE4B protein expression. Conclusion: The low expression of TNFAIP3 and the high expression of PDE4B in diffuse large B cell lymphoma can antagonize tumor cell apoptosis and promote tumor cell invasion.
出处 《Journal of Hainan Medical University》 2017年第24期97-100,共4页 海南医学院学报(英文版)
基金 Projects of Natural Science Foundation of China No:81300397.
  • 相关文献

参考文献2

二级参考文献17

  • 1Menon M P, Pittaluga S, Jaffe E S. The histological and biological spectrum of diffuse large B-cell lymphoma in the WHO classifica- tion[J]. Cancer J, 2012,18(5) :411 -20.
  • 2Hymowitz S G, Wertz I E. A20: from ubiquitin editing to tumour suppression[J]. Nat Rev Cancer, 2010,10(5) :332 -41.
  • 3Chanudet E, Huang Y, Ichimura K, et al. A20 is targeted by pro- rooter methylation, delc-tion and inactivating mutation in MALTlymphoma [ J ]. Leukemia, 2010,24 ( 2 ) :483 - 7.
  • 4Davis R E, Brown K D, Siebenlist U, et al. Constitutive nuclear faetor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells[J]. J Exp Med, 2001,194 (12) :1861 -74.
  • 5Kojima K, Fujino Y, Goto-Koshino Y, et al. Analysis on activation of NF-KB and eft~ct of bortezomib in canine neoplastic lymphoid cell lines[J]. J Vet Med Sci, 2013,75(6) :727 -31.
  • 6Opipari A W Jr, Boguski M S, Dixit V M. The A20 cDNA induced by tumor necrosis factor alpha encodes a novel type of zinc finger protein [ J ]. Biol Chem, 1990,265 ( 25 ) : 14705 - 8.
  • 7Vereecke L, Beyaert R, Van Loo G, et al. The ubiquitin-editing enzyme A20 ( TNFAIP3 ) is a central regulator of immunopathology [J]. Trends Immunol, 2009,30 ( 8 ) : 383 - 91.
  • 8Weaver E A, Chen C Y, May S M, et al. Comparison of adenovi- ruses as oncolytics and cancer vaccines in an immunocompetent n cell lymphoma model[ J ]. Hum Gcne Ther, 2011,22 (9) : 1095 - 100.
  • 9DOU Ai-xia,WANG Xin.Cyclic adenosine monophosphate signal pathway in targeted therapy of lymphoma[J].Chinese Medical Journal,2010(1):95-99. 被引量:10
  • 10李扬秋.A20的免疫调节作用及其临床意义[J].中国实验血液学杂志,2011,19(4):851-856. 被引量:14

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部